Onconova Therapeutics, Inc. Gains 28.45%
Tue, Dec 01, 2020 at 05:32 PM
Onconova Therapeutics, Inc. (ONTX:NASDAQ) rocketted at $0.37, a gain of 28.4%. On Mon 30 Nov 20, ONTX:NASDAQ hit a New 2-Week High of $0.29. The stock appeared on our News Catalysts scanner on Mon 23 Nov 20 at 10:59 AM in the 'INVESTOR UPDATE' category. From Mon 16 Nov 20, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Mon 21 Sep 20 at $0.44 with a volume of 101M+, and its share price has been moving sideways in recent weeks.
About Onconova Therapeutics, Inc. (ONTX:NASDAQ)
Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule drug candidates to treat cancer. The Company has three clinical-stage product candidates and six preclinical programs.
Top 10 Gainers:
- Auris Medical Holding Ltd. (EARS:NASDAQ), 371.17%
- STWO (STWO:NASDAQ), 100%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 54.32%
- TDH Holdings, Inc. (PETZ:NASDAQ), 53.79%
- Corporacion America Airports S.A. (CAAP:NYSE), 42.99%
- DIRTT Environmental Solutions Ltd. (DRTT:NASDAQ), 32.93%
- Arlo Technologies, Inc. (ARLO:NYSE), 31.18%
- Jaguar Health, Inc. (JAGX:NASDAQ), 30.89%
- CollPlant Biotechnologies Ltd. (CLGN:NASDAQ), 29%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 28.45%